REFRACTORY CHILDHOOD ACUTE MYELOID LEUKEMIA
Clinical trials for REFRACTORY CHILDHOOD ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY CHILDHOOD ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY CHILDHOOD ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with Tough-to-Treat leukemia
Disease control Recruiting nowThis early-stage study is testing a new drug, imetelstat, combined with two standard chemotherapy drugs (fludarabine and cytarabine) in children and young adults. It aims to find the safest dose and see if this combination can help control three types of aggressive blood cancers …
Matched conditions: REFRACTORY CHILDHOOD ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for youngest leukemia patients: first trial of groundbreaking cell therapy
Disease control Recruiting nowThis study is testing a new, experimental cell therapy for children under 6 years old with a specific, hard-to-treat type of acute myeloid leukemia (AML) that has come back or not responded to other treatments. Doctors will collect a child's own immune cells, modify them in a lab…
Matched conditions: REFRACTORY CHILDHOOD ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC